NAM
GOSS icon

NorthCrest Asset Manangement’s Gossamer Bio GOSS Stock Holding History

NorthCrest Asset Manangement’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16K Sell
23,783
-903
-4% -$252 ﹤0.01% 929
2026
Q1 		$9.13K Buy
24,686
+13,202
+115% +$20.8K ﹤0.01% 765
2025
Q4 		$31.5K Buy
+11,484
New +$32.8K ﹤0.01% 813

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MGW
MB Generational Wealth Spokane, Washington $204M AUM 25.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NorthCrest Asset Manangement's GOSS Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Gossamer Bio (GOSS) stake by 3.7% in Q2 2026, selling an estimated $252 and leaving 23,783 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

NorthCrest Asset Manangement first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $31.5K in Q4 2025. 66 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • NorthCrest Asset Manangement held 23,783 shares of Gossamer Bio worth $4.16K as of Q2 2026.
  • NorthCrest Asset Manangement sold 903 Gossamer Bio shares in Q2 2026, an estimated $252.
  • Gossamer Bio made up ﹤0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #929 holding.
  • NorthCrest Asset Manangement first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • NorthCrest Asset Manangement's Gossamer Bio position peaked at $31.5K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.